Professional Certificate Biosimilars: Clinical Trials
-- ViewingNowThe Professional Certificate Program in Biosimilars: Clinical Trials is a comprehensive course designed to meet the growing industry demand for professionals with expertise in biosimilars. This program equips learners with essential skills required to understand the complexities of biosimilars, their development, and clinical trials.
3,657+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Introduction to Biosimilars: Understanding the basics of biosimilars, including definition, manufacturing process, and key differences with generic drugs.
⢠Regulatory Guidelines: Overview of regulatory frameworks for biosimilars in major markets, including the US, Europe, and Asia.
⢠Clinical Development: Outlining the clinical development process for biosimilars, including preclinical, phase I, II, and III trials.
⢠Comparability Studies: Examining the role of comparability studies in establishing biosimilarity, including analytical, non-clinical, and clinical comparability assessments.
⢠Immunogenicity Assessment: Assessing the immunogenicity of biosimilars, including clinical and regulatory considerations.
⢠Extrapolation of Indications: Exploring the concept of extrapolation of indications, including its rationale, limitations, and regulatory requirements.
⢠Risk Management and Pharmacovigilance: Managing risks and pharmacovigilance for biosimilars, including safety monitoring, risk minimization strategies, and post-marketing surveillance.
⢠Interchangeability and Switching: Understanding the concept of interchangeability, its implications for clinical practice, and regulatory requirements in various markets.
⢠Market Access and Reimbursement: Examining the market access and reimbursement landscape for biosimilars, including pricing strategies, market uptake, and policy considerations.
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëŹ¸
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë
